Replies to post #75066 on PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

That post is greatly appreciated Trip! :) :) :)

[$Pistol Pete$]

$PMCB nice post


$PMCB has medical and scientific professionals with the following CURRENT associations:

Dr. Sher, Chief Medical Officer, CURRENTLY a Professor at University of Southern California’s Keck School of Medicine

Dr. Günzburg, Chief Science Officer, CURRENTLY a Professor at University of Vienna

Dr. Löhr, Chair of PMCB's Medical and Scientific Advisory Board, CURRENTLY a Professor at Karolinska Institute and CURRENTLY a Member of German Cancer Research Centre

Dr. Brandtner, Director of Diabetes Program, CURRENTLY the Head of the Bioencapsulation at the Vorarlberg Institute for Vascular Investigation and Treatment, and CURRENTLY a member of European Association for the Study of Diabetes (EASD), the Austrian Diabetes Association (ÖDG) and the European Society for Gene and Cell Therapy (ESGCT)

Dr. Rabe, Director of Cannabis Program, CURRENTLY running the cannabis program at University of Northern Colorado

Dr. Abecassis, Board Member, CURRENTLY a surgeon and the director of the Transplant Center at Northwestern University Feinberg School of Medicine

Dr. Hidalgo, Advisory Board Member, CURRENTLY Director of the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC)

Dr. Hammes, Advisory Board Member, CURRENTLY a Professor at Heidelberg University

FURTHERMORE, the management team has years of experience at top pharma companies:

Mr. Liquard, Board Member, 7 years at Pfizer

Dr. Crabtree, Board Member, 7 years at Bristol-Myers Squibb

Dr. Günzburg, CSO, 7 years at Bavarian Nordic

FINALLY, between all of these professional there are HUNDREDS of published, peer reviewed scientific articles

Would these professionals be risking their personal reputations and the reputations of their hospitals and universities by being associated with any shady organization? I say that suggestion is absurd.